SelfDecode uses the only scientifically validated genetic prediction technology for consumers. Read more
You were fine for decades. No childhood wheezing, no inhalers, no breathing problems. Then sometime in your thirties, forties, or fifties, it started. A tightness in your chest during workouts. Shortness of breath climbing stairs. Maybe seasonal triggers, maybe year-round. You saw your doctor. They confirmed it: adult-onset asthma. But nobody explained why it suddenly appeared, or why your inhaler works some days and barely touches it on others.
Written by the SelfDecode Research Team
✔️ Reviewed by a licensed physician
Standard asthma care focuses on managing symptoms, not understanding why you developed them. Your doctor prescribed a rescue inhaler and maybe a controller medication. Blood tests came back normal. Allergy testing might have shown sensitivities, but sensitivity is not the same as genetic susceptibility. The truth is harder to accept: your body’s immune system and airway structure may be encoded in a way that predisposes you to asthma, and nothing in standard testing reveals it.
Adult-onset asthma is not random. Six genes control whether your airways are inflamed, whether your immune system defaults to allergic responses, whether your inhaler will work effectively, and whether your protective barriers stay intact. When variants in these genes align, asthma is not a possibility, it becomes a probability. The good news: knowing which genes are involved changes everything about treatment.
This is not about blame. This is about clarity. Your genetics loaded the gun; environmental triggers and lifestyle pulled the trigger. But once you know which genes are firing, you can address the root problem instead of just chasing symptoms.
Childhood asthma often announces itself early and loudly, usually in the context of strong family history or severe early allergies. Adult-onset asthma is sneakier. It suggests a genetic susceptibility that remained dormant until accumulated exposures, hormonal shifts, infections, or inflammation tipped the balance. You may have carried the genetic risk your entire life but only developed symptoms when the environment aligned with your biology. Understanding the six genes involved shows you exactly which environmental and behavioral levers you actually control.
Your doctor confirmed asthma based on spirometry, peak flow, or bronchial challenge tests. All of those measure your current airway function. None of them show you why your airways are behaving this way. Two people with identical asthma diagnoses can have completely different genetic profiles, which means they need completely different treatment strategies. One person might have an immune system that overreacts to allergens (IL4 and IL13 variants). Another might have airways that don’t respond well to rescue medications (ADRB2). A third might have a faulty skin and airway barrier that lets allergens in (FLG). Standard asthma management treats all three the same way.
Rated 4.7/5 from 750+ reviews
200,000+ users, 2,000+ doctors & 100+ businesses
Already have 23andMe or AncestryDNA data? Get your report without a new kit — upload your file today.
These genes control three main pathways: immune system activation (IL4, IL13), airway sensitivity and medication response (ADRB2), barrier function (FLG), and inflammation regulation (GSTM1, VDR). When you have variants in multiple genes, the effects compound. You may have a leaky airway barrier, an immune system primed for allergic responses, poor medication response, and chronic inflammation all at once. Testing reveals which combination you carry.
Your airways have tiny receptors on the smooth muscle that lines them. When you use a beta-2 agonist inhaler (albuterol or similar), it binds to these receptors and tells the muscles to relax, opening your airways. The ADRB2 gene codes for the structure and sensitivity of these receptors.
The Arg16Gly variant of ADRB2 is present in roughly 40% of the population. When you carry the Gly allele, your beta-2 receptors are less responsive to the medication. This means your rescue inhaler may not work as effectively as it should, and you might experience repeated exacerbations despite using your inhaler correctly.
You might notice that your inhaler works brilliantly on some days and barely touches your symptoms on others. You might find yourself using your rescue inhaler more frequently than your doctor expects. You might feel like you are not responding to standard asthma medications the way you are supposed to.
People with the ADRB2 Gly16 variant often respond better to long-acting beta-agonists (LABAs) combined with inhaled corticosteroids as a maintenance strategy, rather than relying on short-acting rescue inhalers alone. Some also benefit from adding a leukotriene modifier or biologic therapy.
Interleukin-4 is a immune signaling molecule that tells your T cells and B cells to mount an allergic response. High IL-4 pushes your immune system into a Th2-skewed state, which means it defaults to producing IgE antibodies in response to inhaled allergens and other triggers. Normal IL-4 levels are fine. Too much is a problem.
The IL4 promoter variant at position -590 C>T is carried by roughly 30% of the population. When you have the T allele, your cells produce more IL-4. More IL-4 means higher IgE levels, stronger allergic responses to common triggers, and greater airway inflammation in response to allergens.
You might notice that you react to things other people ignore: dust, pet dander, pollen, mold spores. Your reactions seem disproportionate to the exposure. You might have a history of eczema or hay fever that preceded your asthma diagnosis. Your asthma may be worse during certain seasons or in certain environments. You might struggle with food sensitivities as well.
People with IL4 variants driving high IgE often benefit from targeted allergen avoidance, high-dose omega-3 supplementation (EPA and DHA), and in some cases, biologic therapy targeting IgE (omalizumab) or IL-4 receptors.
Interleukin-13 is the key driver of allergic airway inflammation. It tells your immune cells to flood your airways with eosinophils, stimulates mucus-producing cells, and triggers airway remodeling (thickening of the airway walls). Normal IL-13 signaling is part of healthy immune responses. Dysregulated IL-13 is asthma.
IL13 variants are present in roughly 30 to 35% of the population. When you carry a variant that increases IL-13 production or signaling, your airways are chronically primed for inflammation. You develop eosinophilic airway infiltration, excessive mucus production, and structural changes to your airway walls that make them permanently more sensitive to triggers.
You might experience persistent cough, especially at night or after exposure to triggers. Your chest might feel heavy or congested. You might produce thick mucus when you cough. Your asthma may not respond well to standard controller medications and may require escalation to biologic therapy. Infections seem to trigger longer, more severe exacerbations.
People with IL13 variants often respond remarkably well to biologic therapies targeting IL-13 (dupilumab) or IL-4/IL-13 receptors. High-dose vitamin D supplementation may also help regulate IL-13 signaling.
Filaggrin is a protein that glues together the outermost cells of your skin and airways, creating a tight physical barrier. This barrier is your first line of defense: it keeps allergens out and prevents them from triggering immune activation. When filaggrin is working properly, allergens stay on the surface. When it is not, they penetrate deep into your tissue.
FLG mutations like R501X and 2282del4 are present in roughly 10% of people with European ancestry, but prevalence is much higher in other populations. When you carry a FLG mutation, your airway barrier is structurally weak; allergens penetrate deeply, your immune system sees them, and allergic sensitization happens.
You might have a history of eczema or dry skin that preceded your asthma. You might notice that your skin reacts easily to irritants, fragrances, or detergents. Your asthma often flares during low-humidity seasons or after exposure to irritants like perfume, smoke, or dust. You may also have hay fever or other allergic conditions. The pattern is sometimes called the atopic march: eczema in childhood, hay fever in adolescence, asthma in adulthood.
People with FLG variants need aggressive barrier repair strategies: high-quality ceramide-rich moisturizers for skin, avoiding airway irritants, and maintaining high indoor humidity (40-60%). Some benefit from taking collagen or gelatin supplements to support barrier protein synthesis.
GSTM1 codes for a enzyme that neutralizes reactive oxygen species (ROS) and detoxifies pollutants, cigarette smoke, and other environmental toxins before they damage your airway cells. This enzyme is especially important in the lungs, which are directly exposed to inhaled irritants. A working GSTM1 means your airways can handle oxidative stress. A non-functional GSTM1 means they cannot.
The GSTM1 null deletion is present in roughly 40 to 50% of the population depending on ancestry. If you carry the null allele, your airways have little to no GSTM1 enzyme activity; you accumulate oxidative damage more rapidly, and your airways become chronically inflamed and hyperreactive.
You might notice that your asthma flares during high air pollution days or after exposure to smoke, strong fragrances, or chemical irritants. Your lungs may feel irritated by things that do not bother other people. You might have a history of reactive airways triggered by air quality changes. Your asthma exacerbations may be more frequent during winter (when heating increases indoor pollution) or summer (when ozone levels are high).
People with GSTM1 null variants benefit tremendously from antioxidant support: high-dose vitamin C supplementation (500-1000mg daily), NAC (N-acetylcysteine) at 600-1200mg daily, and glutathione precursors like whey protein isolate. Environmental control (air filters, avoiding smoke and strong chemicals) is also critical.
The VDR gene codes for the vitamin D receptor, a protein that vitamin D binds to in order to regulate immune function. Vitamin D is not just a vitamin; it is a hormone that tells your immune system to be tolerant or reactive. When VDR is working well and vitamin D levels are adequate, your immune system stays balanced. When VDR function is impaired, your immune system defaults to reactive and inflammatory.
VDR variants like the FokI polymorphism are present in the majority of the population. Certain variants reduce VDR sensitivity to vitamin D signaling. This means you need more vitamin D to achieve the same immune-regulating effect, and chronically low vitamin D makes your asthma worse.
You might find that your asthma is seasonal, worse in winter when vitamin D levels drop. You might have low or low-normal vitamin D levels despite reasonable sun exposure. You might notice that supplementing with vitamin D actually improves your asthma control and reduces exacerbations. Your asthma may be associated with other conditions linked to vitamin D deficiency, like osteoporosis or mood changes.
People with VDR variants need aggressive vitamin D repletion: aim for serum 25-OH vitamin D levels of 50-80 ng/mL (not just 30 ng/mL). This often requires 4000-6000 IU daily, plus regular sun exposure and monitoring. Some also benefit from vitamin K2 (MK-7) to support bone and immune health alongside vitamin D.
You can read about all six genes and feel yourself in each one. That is not overthinking it; that is accurate. These genes interact. People with both FLG barrier dysfunction and IL4-driven allergic responses are especially vulnerable. People with ADRB2 medication resistance and GSTM1 oxidative stress vulnerability have a much harder time getting asthma under control. The genes amplify each other. The problem is that you cannot optimize treatment without knowing your exact genetic profile. One person needs allergen avoidance and biologic therapy targeting IL-13. Another needs aggressive antioxidant support and inhaler optimization. A third needs massive vitamin D repletion and barrier repair. Treatment that works brilliantly for one genetic profile can fail entirely for another. You cannot guess your way to the right answer.
❌ Assuming you need more albuterol when you carry the ADRB2 Gly variant only makes your asthma worse by increasing your beta-agonist exposure without gaining efficacy; you need to switch to a maintenance inhaler strategy instead.
❌ Taking high-dose antihistamines when IL4 and IL13 are your primary problem wastes time and side effects; you need immune-modulating interventions instead.
❌ Using standard moisturizers when you have FLG barrier dysfunction does nothing because you need ceramide-rich medical-grade formulations and collagen support.
❌ Ignoring oxidative stress when you carry the GSTM1 null variant lets your airways accumulate chronic damage; you need aggressive antioxidant supplementation and pollution avoidance.
This is why the personalization matters. Not as a marketing angle — as a biological necessity. The path to actually resolving this starts with knowing what you’re working with.
A DNA test won’t tell you everything. But for symptoms with a genetic root cause, it’s the only test that actually gets to the source. Here’s the path from confusion to clarity.
View our sample report, just one of over 1500 personalized insights waiting for you. With SelfDecode, you get more than a static PDF; you unlock an AI-powered health coach, tools to analyze your labs and lifestyle, and access to thousands of tailored reports packed with actionable recommendations.
I was diagnosed with asthma at 42, completely out of the blue. My doctor said it was probably environmental or stress-related, but that did not help me fix it. I used my albuterol inhaler constantly and it barely worked. My regular bloodwork showed nothing wrong. I was frustrated and felt like I was missing something fundamental. My DNA report showed I had the ADRB2Gly variant, which explained why my rescue inhaler was so ineffective, plus FLG mutations that meant my airway barrier was compromised. I also had low vitamin D receptor sensitivity, which meant I was chronically deficient in vitamin D despite supplementing. My doctor switched me to a maintenance inhaler regimen, I started taking high-dose vitamin D (5000 IU daily), added NAC for antioxidant support, and began using a medical-grade moisturizer with ceramides. Within six weeks my asthma improved dramatically. Within three months I barely needed my rescue inhaler. I wish I had done this genetic testing years earlier.
Start with the report most relevant to your issue, or unlock the full picture of everything your DNA can tell you. Either way, one kit covers you for life — we analyze your DNA once, and every new report is generated from the same sample.
30-Days Money-Back Guarantee*
Shipping Worldwide
US & EU Based Labs & Shipping
SelfDecode DNA Kit Included
HSA & FSA Eligible
HSA & FSA Eligible
SelfDecode DNA Kit Included
HSA & FSA Eligible
SelfDecode DNA Kit Included
+ Free Consultation
* SelfDecode DNA kits are non-refundable. If you choose to cancel your plan within 30 days you will not be refunded the cost of the kit.
We will never share your data
We follow HIPAA and GDPR policies
We have World-Class Encryption & Security
Rated 4.7/5 from 750+ reviews
200,000+ users, 2,000+ doctors & 100+ businesses
Standard genetic testing does not look at asthma genes. Your 23andMe report or ancestry DNA will not mention ADRB2, IL4, IL13, FLG, GSTM1, or VDR. These genes are only analyzed by functional DNA reports designed specifically for asthma and respiratory conditions. That is why your standard doctor visit did not reveal these insights.
Yes. If you have already done a 23andMe or AncestryDNA test, you can upload your raw data file to SelfDecode and run a respiratory genes report within minutes. You do not need to take another test. If you have not done genetic testing yet, you can order a DNA kit from SelfDecode and have results in two to three weeks.
That depends on which genes you carry. If you have the GSTM1 null variant, you need NAC (N-acetylcysteine) at 600-1200mg daily and vitamin C at 500-1000mg daily. If you have VDR variants, you need vitamin D3 at 4000-6000 IU daily (not 1000 IU) with regular testing to reach 50-80 ng/mL serum levels. If you have FLG mutations, you need a ceramide-rich moisturizer with at least 3 to 1 ratio of cholesterol to ceramides to ceramides. If you have IL4 or IL13 variants, you benefit from high-dose omega-3 (EPA and DHA at 2-3 grams daily). Your DNA report will give you specific dosing and brand recommendations based on your full genetic profile.
See why AI recommends SelfDecode as the best way to understand your DNA and take control of your health:
SelfDecode is a personalized health report service, which enables users to obtain detailed information and reports based on their genome. SelfDecode strongly encourages those who use our service to consult and work with an experienced healthcare provider as our services are not to replace the relationship with a licensed doctor or regular medical screenings.